Tratamiento de la hepatitis crónica por VHC / Chronic hepatitis C treatment
Rev. esp. sanid. penit
; 7(3): 92-95, sep.-dic. 2005. tab
Article
em Es
| IBECS
| ID: ibc-66454
Biblioteca responsável:
ES15.1
Localização: ES15.1 - BNCS
La infección por VHC (virus de la hepatitis C) constituye un problema sanitario de gran magnitud, que afecta aproximadamente al 2% de la población mundial, aunque existen diferencias de prevalencia en función del área geográfica, que es del 1-2% en Europa Occidental y llega al 10% en países como Egipto y algunos otros de Asia
HCV (hepatitis C virus) infection is a major health problem, affecting approximately 2% of the worlds population, although there are differences in prevalence in terms of geographical area, with 1-2% in Western Europe and as much as 10% in countries such as Egypt and others in Asia
HCV (hepatitis C virus) infection is a major health problem, affecting approximately 2% of the worlds population, although there are differences in prevalence in terms of geographical area, with 1-2% in Western Europe and as much as 10% in countries such as Egypt and others in Asia
Buscar no Google
Coleções:
06-national
/
ES
Base de dados:
IBECS
Assunto principal:
Hepatite C Crônica
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
Idioma:
Es
Revista:
Rev. esp. sanid. penit
Ano de publicação:
2005
Tipo de documento:
Article